Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Income towards Parent Company: 2010-2012

Historic Income towards Parent Company for Sonoma Pharmaceuticals (SNOA) over the last 3 years, with Dec 2012 value amounting to -$954,000.

  • Sonoma Pharmaceuticals' Income towards Parent Company rose 63.49% to -$954,000 in Q4 2012 from the same period last year, while for Dec 2012 it was -$4.6 million, marking a year-over-year increase of 36.33%. This contributed to the annual value of -$7.4 million for FY2012, which is 6.50% up from last year.
  • Per Sonoma Pharmaceuticals' latest filing, its Income towards Parent Company stood at -$954,000 for Q4 2012, which was up 12.96% from -$1.1 million recorded in Q3 2012.
  • In the past 5 years, Sonoma Pharmaceuticals' Income towards Parent Company ranged from a high of -$782,000 in Q2 2012 and a low of -$2.6 million during Q4 2011.
  • For the 3-year period, Sonoma Pharmaceuticals' Income towards Parent Company averaged around -$1.6 million, with its median value being -$1.7 million (2010).
  • The largest annual percentage gain for Sonoma Pharmaceuticals' Income towards Parent Company in the last 5 years was 64.11% (2012), contrasted with its biggest fall of 27.59% (2012).
  • Sonoma Pharmaceuticals' Income towards Parent Company (Quarterly) stood at -$2.2 million in 2010, then declined by 19.59% to -$2.6 million in 2011, then surged by 63.49% to -$954,000 in 2012.
  • Its Income towards Parent Company stands at -$954,000 for Q4 2012, versus -$1.1 million for Q3 2012 and -$782,000 for Q2 2012.